Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. [GOC:ai]
The T cell receptor (TCR) signaling pathway is a complex and tightly regulated process that plays a crucial role in adaptive immunity. It allows T cells to recognize and respond to specific antigens presented by antigen-presenting cells (APCs), leading to the activation and differentiation of T cells into effector cells that can eliminate infected or cancerous cells.
The TCR signaling pathway is initiated when the TCR on the surface of a T cell recognizes and binds to a specific antigen-MHC complex presented by an APC. This binding event triggers a cascade of intracellular signaling events that ultimately lead to the activation of transcription factors that induce the expression of genes required for T cell activation, proliferation, and differentiation.
Here is a detailed description of the key steps involved in the regulation of the TCR signaling pathway:
**1. TCR Engagement and Initial Signaling:**
* The TCR is a multi-protein complex consisting of the TCRαβ heterodimer, CD3 complex (CD3εγ, CD3εδ, and CD3ζζ), and ζ-associated protein of 70 kDa (ZAP-70).
* When the TCR binds to an antigen-MHC complex, it triggers the phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) within the cytoplasmic tails of the CD3 complex.
* These phosphorylated ITAMs serve as docking sites for the Src family tyrosine kinase, Lck.
* Lck phosphorylates the tyrosine residues within the ITAMs, creating binding sites for ZAP-70.
**2. ZAP-70 Activation and Downstream Signaling:**
* ZAP-70 binds to the phosphorylated ITAMs and becomes activated.
* Activated ZAP-70 phosphorylates two key downstream adaptor proteins: linker for activation of T cells (LAT) and SLP-76.
* Phosphorylation of LAT and SLP-76 creates docking sites for other signaling molecules, including phospholipase Cγ1 (PLCγ1), Grb2, and Vav1.
**3. Calcium Signaling and NFAT Activation:**
* PLCγ1, recruited to the LAT-SLP-76 complex, hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3).
* IP3 binds to receptors on the endoplasmic reticulum (ER), releasing calcium ions (Ca2+) into the cytoplasm.
* Increased intracellular calcium levels activate calcineurin, a calcium-dependent phosphatase.
* Calcineurin dephosphorylates and activates nuclear factor of activated T cells (NFAT), which translocates to the nucleus.
**4. MAPK Signaling and AP-1 Activation:**
* DAG activates protein kinase C (PKC), which in turn activates the mitogen-activated protein kinase (MAPK) pathway.
* The MAPK pathway leads to the activation of transcription factors such as activator protein 1 (AP-1).
**5. Transcriptional Activation and T Cell Activation:**
* NFAT, AP-1, and other transcription factors cooperate to induce the expression of genes required for T cell activation, proliferation, and differentiation.
* These genes include those encoding cytokines (e.g., IL-2, IFN-γ), chemokines, adhesion molecules, and other proteins involved in T cell function.
**6. Regulation of TCR Signaling:**
* The TCR signaling pathway is tightly regulated to prevent excessive or inappropriate activation of T cells.
* Negative regulatory mechanisms include:
* **Phosphatases:** SHP-1, SHP-2, and CD45 dephosphorylate key signaling molecules, reducing their activity.
* **Inhibitory receptors:** CTLA-4 and PD-1 inhibit TCR signaling by interacting with co-stimulatory molecules on APCs.
* **Ubiquitination and degradation:** Proteins involved in TCR signaling can be ubiquitinated and targeted for degradation, limiting signal duration.
* **Desensitization:** Prolonged TCR stimulation can lead to desensitization, preventing excessive activation.
The regulation of TCR signaling is crucial for maintaining immune homeostasis and preventing autoimmune diseases. Defects in TCR signaling can lead to immunodeficiency or autoimmunity.
'"
Protein | Definition | Taxonomy |
---|---|---|
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | A mucosa-associated lymphoid tissue lymphoma translocation protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UDY8] | Homo sapiens (human) |
Receptor-type tyrosine-protein phosphatase C | A receptor-type tyrosine-protein phosphatase C that is encoded in the genome of human. [PRO:CNA, UniProtKB:P08575] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
4-hydroxyphenylglyoxylic acid | 4-hydroxyphenylglyoxylate : Conjugate base of 4-hydroxyphenylglyoxylic acid. 4-hydroxyphenylglyoxylic acid: RN given refers to parent cpd | phenols | |
5-iodo-2-(oxaloamino)benzoic acid | organoiodine compound | ||
beta-lapachone | beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities. beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
thioridazine | thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position. Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA. | phenothiazines; piperidines | alpha-adrenergic antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
mepazine | mepazine: major descriptor (66-85); on-line search PHENOTHIAZINES (66-85); Index Medicus search MEPAZINE (66-85); RN given refers to parent cpd pacatal : A phenothiazine derivative in which 10H-phenothiazine has an N-methylpiperidin-4-ylmethyl substituent at the N-10 position. | phenothiazines | |
9,10-phenanthrenequinone | 9,10-phenanthrenequinone: structure | phenanthrenes | |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
1,2-naphthoquinone | 1,2-naphthoquinone : The parent structure of the family of 1,2-naphthoquinones, in which the oxo groups of the quinone moiety are at positions 1 and 2 of the naphthalene ring. It is a metabolite of naphthalene and is found in diesel exhaust particles. naphthalene-1,2-dione: structure given in first source | 1,2-naphthoquinones | aryl hydrocarbon receptor agonist; carcinogenic agent |
cryptotanshinone | cryptotanshinone: from Salvia miltiorrhiza | abietane diterpenoid | anticoronaviral agent |
2-(oxaloamino)benzoic acid | (oxaloamino)benzoic acid | ||
illudalic acid | illudalic acid: isolated from Clitocybe illudens; structure in first source | ||
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid | 3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1H-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1H-indole-5-carboxylic acid: an SHP2 inhibitor; structure in first source | ||
variabilin | variabilin: an RGD-containing antagonist of glycoprotein IIb-IIIa from the hard tick, Dermacentor variabilis; amino acid sequence given in first source |